sniff
.
trade
shows
track
profile
⌘K
request access
Adam Feuerstein ✡️ — sniff.trade
← all shows
AF
Adam Feuerstein ✡️
follow
following
unfollow
2 episodes · 3 trades · 1 speakers
all speakers
▾
newest
best pnl
TRACKED TRADES
AF
@adamfeuerstein
1mo
Viridian Therapeutics, Inc. - Viridian Therapeutics Announces U.S. FDA Approval and Launch of Lumvoa™ (veligrotug-vvze) for the Treatment of Thyroid Eye Disease
IDEAS · 1
VRD
VRDN
LONG
FDA approves Viridian's Lumvoa for thyroid eye disease — a major binary catalyst that sends VRDN sharply higher.
$19.18
+4.78%
›
AF
@adamfeuerstein
1mo
FDA advisory committee meetings are back. $CAPR deramiocel will be reviewed on July 2…
IDEAS · 2
CAP
CAPR
LONG
FDA AdCom for CAPR's deramiocel confirmed for July 29, a binary binary catalyst ahead of Aug 22 PDUFA date for DMD cell therapy.
$3.90
-85.59%
›
REP
REPL
LONG
FDA AdCom for REPL's RP1 oncolytic therapy confirmed for late July, just days ahead of an August 2 approval decision for advanced melanoma.
$11.40
-1.93%
›
